image
REGENXBIO Inc. RGNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.63
-13.6 %
$ 477 M
Market Cap
-1.92
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -19.94% 6.00% -2.00%
Annual Report FY 10-K 2022-12-31 -76.03% -219.27% -164.32%
Annual Report FY 10-K 2021-12-31 204.30% 214.91% 234.17%
Annual Report FY 10-K 2020-12-31 338.70% -17.44% 19.98%
Annual Report FY 10-K 2019-12-31 -83.88% -94.79% -169.12%
Annual Report FY 10-K 2018-12-31 2002.42% 236.58% 216.10%
Annual Report FY 10-K 2017-12-31 126.48% -16.20% -16.14%
Annual Report FY 10-K 2016-12-31 -39.52% -176.04% -182.40%
Annual Report FY 10-K 2015-12-31 23.99% -469.85% -528.38%
Annual Report FY 10-K 2014-12-31 0.54% 25.69% 22.91%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -16.31% 3.67% 4.44%
Quarterly Report Q2 8-K 2024-06-30 11.60% 26.47% 23.35%
Quarterly Report Q1 8-K 2024-03-31 -18.37% 9.46% 6.64%
Quarterly Report Q4 8-K 2023-12-31 -29.13% -4.93% -10.61%
Quarterly Report Q3 8-K 2023-09-30 9.06% 22.59% 8.56%
Quarterly Report Q2 8-K 2023-06-30 -38.81% -5.69% -16.91%
Quarterly Report Q1 8-K 2023-03-31 -13.86% 8.83% 7.51%
Quarterly Report Q4 8-K 2022-12-31 -92.14% -20.38% -18.42%
Quarterly Report Q3 8-K 2022-09-30 -13.85% -36.84% -23.88%
Quarterly Report Q2 8-K 2022-06-30 48.17% -18.29% -19.74%
Quarterly Report Q1 8-K 2022-03-31 17.66% -53.02% -62.41%
Quarterly Report Q4 8-K 2021-12-31 1758.96% 735.85% 684.51%
Quarterly Report Q3 8-K 2021-09-30 -68.89% -664.37% -411.07%
Quarterly Report Q2 8-K 2021-06-30 33.01% -70.72% -24.84%
Quarterly Report Q1 8-K 2021-03-31 7.03% -25.23% -16.82%
Quarterly Report Q4 8-K 2020-12-31 82.23% -74.73% -33.05%
Quarterly Report Q3 8-K 2020-09-30 572.87% 125.42% 138.87%
Quarterly Report Q2 8-K 2020-06-30 110.20% -2217.23% -13.45%
Quarterly Report Q1 8-K 2020-03-31 1895.93% -24.23% -5.00%
Quarterly Report Q4 8-K 2019-12-31 -71.14% -614.58% -1645.88%
Quarterly Report Q3 8-K 2019-09-30 177.04% -80.11% -57.96%
Quarterly Report Q2 8-K 2019-06-30 -80.31% -13.75% -580.66%
Quarterly Report Q1 8-K 2019-03-31 -99.33% -30.92% -35.19%
Quarterly Report Q4 8-K 2018-12-31 1898.87% 126.92% 114.76%
Quarterly Report Q3 8-K 2018-09-30 297.16% 7.26% -6.65%
Quarterly Report Q2 8-K 2018-06-30 510.04% 173.20% 142.18%
Quarterly Report Q1 8-K 2018-03-31 28996.92% 573.96% 545.10%
Quarterly Report Q4 8-K 2017-12-31 20.28% 18.42% 18.91%
Quarterly Report Q3 8-K 2017-09-30 968.80% -14.06% -14.15%
Quarterly Report Q2 8-K 2017-06-30 176.29% -0.25% -0.70%
Quarterly Report Q1 8-K 2017-03-31 15.78% -104.24% -103.73%
Quarterly Report Q4 8-K 2016-12-31 -61.81% -278.68% -272.10%
Quarterly Report Q3 8-K 2016-09-30 -89.04% -147.60% -154.09%
Quarterly Report Q2 8-K 2016-06-30 74.25% -129.52% -137.48%
Quarterly Report Q1 8-K 2016-03-31 -38.98% -168.46% -181.77%
Quarterly Report Q4 8-K 2015-12-31 286.85% -121.66% -148.13%
Quarterly Report Q3 8-K 2015-09-30 136.02% -308.92% -331.92%
Quarterly Report Q2 8-K 2015-06-30 -12.01% -1027.24% -947.59%
Quarterly Report Q1 8-K 2015-03-31 -78.07% -1874.30% -486.36%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%